The loss of PTEN activity, identified in a series of primary and metastatic tumors, such as breast cancer, leads into uncontrolled transduction of the PI3K signal which is involved in a series of biological processes, such as cellular motility, invasion, proliferation, and survival [34]. The gene discussed is PTEN; the disease is breast cancer.